Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA I to II Female patients. 2. Aged between 30 to 60 years. 3. Normal liver and renal function test, Coagulation profile. 4. Undergoing Total Laparoscopic Hysterectomy under General Anaesthesia
Exclusion criteria
Exclusion criteria: 1. Patients with history of allergy to local Anaesthetics and Magnesium Sulphate. 2. Patients with history of mental disorders. 3. Patient Refusal. 4. Morbid obesity (BMI >40), Coagulopathy and significant cardiovascular ,respiratory, renal, hepatic or metabolic diseases or CNS disorders. 5. Infection at site of procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Compare the duration of Post operative analgesia using Ropivacaine (0.25%) and Ropivacaine (0.25%) with M.agnesium Sulphate 75mg in bilateral transversus abdominis plane block after Total Laparoscopic Hysterectomy.Timepoint: To study the duration of post operative analgesia at 0,1,2,4,8,12,24 ours in the post op period. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hemodynamic parameter like NIBP, HR and SPO2 for 24 hours post operatively. 2. Post operative Visual analogue scale Pain score. 3. Time for first rescue analgesia 4. Adverse effects.Timepoint: First 24 hours monitoring | — |
Countries
India
Contacts
RajaRajeswari Medical College and Hospital.